Influences of hormone-based contraception on depressive symptoms in premenopausal women with major depression

Elizabeth A. Young, Susan G. Kornstein, Anne T. Harvey, Stephen R. Wisniewski, Jennifer Barkin, Maurizio Fava, Madhukar H. Trivedi, A. John Rush

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Objective: Hormone-based contraceptives affect mood in healthy women or in women with premenstrual dysphoric disorder (PMDD). No study has yet examined their association with mood in women with major depressive disorder (MDD). The purpose of this study was to determine whether estrogen-progestin combination or progestin-only contraceptives are associated with depression severity, function and quality of life, or general medical or psychiatric comorbidity in women with MDD. Methods: This analysis focused on a large population of female outpatients less than 40 years of age with non-psychotic MDD who were treated in 18 primary and 23 psychiatric care settings across the US, using data from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study. Baseline demographic and clinical information was gathered and compared between three groups based on hormonal use: combination (estrogen-progestin)(N=232), progestin-only (N=58), and no hormone treatment (N=948). Results: Caucasians were significantly more likely to use combined hormone contraception. Women on progestin-only had significantly more general medical comorbidities; greater hypersomnia, weight gain and gastrointestinal symptoms; and worse physical functioning than women in either of the other groups. Those on combined hormone contraception were significantly less depressed than those with no hormone treatment by the 16-item Quick Inventory of Depressive Symptomatology-Self-Rated. The combined hormone group also demonstrated better physical functioning and less obsessive-compulsive disorder (COCD) comorbidity than either of the other groups. Conclusions: Synthetic estrogen and progestins may influence depressive and physical symptoms in depressed women.

Original languageEnglish (US)
Pages (from-to)843-853
Number of pages11
JournalPsychoneuroendocrinology
Volume32
Issue number7
DOIs
StatePublished - Aug 2007

Fingerprint

Contraception
Progestins
Hormones
Depression
Major Depressive Disorder
Comorbidity
Contraceptive Agents
Psychiatry
Estrogens
Progesterone Congeners
Disorders of Excessive Somnolence
Estradiol Congeners
Obsessive-Compulsive Disorder
Weight Gain
Outpatients
Therapeutics
Quality of Life
Demography
Equipment and Supplies
Population

Keywords

  • Estradiol
  • Major depression
  • Mood symptoms
  • Norplant
  • Oral contraceptives
  • Progesterone

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Psychiatry and Mental health
  • Biological Psychiatry
  • Endocrine and Autonomic Systems
  • Psychology(all)

Cite this

Young, E. A., Kornstein, S. G., Harvey, A. T., Wisniewski, S. R., Barkin, J., Fava, M., ... Rush, A. J. (2007). Influences of hormone-based contraception on depressive symptoms in premenopausal women with major depression. Psychoneuroendocrinology, 32(7), 843-853. https://doi.org/10.1016/j.psyneuen.2007.05.013

Influences of hormone-based contraception on depressive symptoms in premenopausal women with major depression. / Young, Elizabeth A.; Kornstein, Susan G.; Harvey, Anne T.; Wisniewski, Stephen R.; Barkin, Jennifer; Fava, Maurizio; Trivedi, Madhukar H.; Rush, A. John.

In: Psychoneuroendocrinology, Vol. 32, No. 7, 08.2007, p. 843-853.

Research output: Contribution to journalArticle

Young, Elizabeth A. ; Kornstein, Susan G. ; Harvey, Anne T. ; Wisniewski, Stephen R. ; Barkin, Jennifer ; Fava, Maurizio ; Trivedi, Madhukar H. ; Rush, A. John. / Influences of hormone-based contraception on depressive symptoms in premenopausal women with major depression. In: Psychoneuroendocrinology. 2007 ; Vol. 32, No. 7. pp. 843-853.
@article{b1a57b13692746d6aeed4adabe289a57,
title = "Influences of hormone-based contraception on depressive symptoms in premenopausal women with major depression",
abstract = "Objective: Hormone-based contraceptives affect mood in healthy women or in women with premenstrual dysphoric disorder (PMDD). No study has yet examined their association with mood in women with major depressive disorder (MDD). The purpose of this study was to determine whether estrogen-progestin combination or progestin-only contraceptives are associated with depression severity, function and quality of life, or general medical or psychiatric comorbidity in women with MDD. Methods: This analysis focused on a large population of female outpatients less than 40 years of age with non-psychotic MDD who were treated in 18 primary and 23 psychiatric care settings across the US, using data from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study. Baseline demographic and clinical information was gathered and compared between three groups based on hormonal use: combination (estrogen-progestin)(N=232), progestin-only (N=58), and no hormone treatment (N=948). Results: Caucasians were significantly more likely to use combined hormone contraception. Women on progestin-only had significantly more general medical comorbidities; greater hypersomnia, weight gain and gastrointestinal symptoms; and worse physical functioning than women in either of the other groups. Those on combined hormone contraception were significantly less depressed than those with no hormone treatment by the 16-item Quick Inventory of Depressive Symptomatology-Self-Rated. The combined hormone group also demonstrated better physical functioning and less obsessive-compulsive disorder (COCD) comorbidity than either of the other groups. Conclusions: Synthetic estrogen and progestins may influence depressive and physical symptoms in depressed women.",
keywords = "Estradiol, Major depression, Mood symptoms, Norplant, Oral contraceptives, Progesterone",
author = "Young, {Elizabeth A.} and Kornstein, {Susan G.} and Harvey, {Anne T.} and Wisniewski, {Stephen R.} and Jennifer Barkin and Maurizio Fava and Trivedi, {Madhukar H.} and Rush, {A. John}",
year = "2007",
month = "8",
doi = "10.1016/j.psyneuen.2007.05.013",
language = "English (US)",
volume = "32",
pages = "843--853",
journal = "Psychoneuroendocrinology",
issn = "0306-4530",
publisher = "Elsevier Limited",
number = "7",

}

TY - JOUR

T1 - Influences of hormone-based contraception on depressive symptoms in premenopausal women with major depression

AU - Young, Elizabeth A.

AU - Kornstein, Susan G.

AU - Harvey, Anne T.

AU - Wisniewski, Stephen R.

AU - Barkin, Jennifer

AU - Fava, Maurizio

AU - Trivedi, Madhukar H.

AU - Rush, A. John

PY - 2007/8

Y1 - 2007/8

N2 - Objective: Hormone-based contraceptives affect mood in healthy women or in women with premenstrual dysphoric disorder (PMDD). No study has yet examined their association with mood in women with major depressive disorder (MDD). The purpose of this study was to determine whether estrogen-progestin combination or progestin-only contraceptives are associated with depression severity, function and quality of life, or general medical or psychiatric comorbidity in women with MDD. Methods: This analysis focused on a large population of female outpatients less than 40 years of age with non-psychotic MDD who were treated in 18 primary and 23 psychiatric care settings across the US, using data from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study. Baseline demographic and clinical information was gathered and compared between three groups based on hormonal use: combination (estrogen-progestin)(N=232), progestin-only (N=58), and no hormone treatment (N=948). Results: Caucasians were significantly more likely to use combined hormone contraception. Women on progestin-only had significantly more general medical comorbidities; greater hypersomnia, weight gain and gastrointestinal symptoms; and worse physical functioning than women in either of the other groups. Those on combined hormone contraception were significantly less depressed than those with no hormone treatment by the 16-item Quick Inventory of Depressive Symptomatology-Self-Rated. The combined hormone group also demonstrated better physical functioning and less obsessive-compulsive disorder (COCD) comorbidity than either of the other groups. Conclusions: Synthetic estrogen and progestins may influence depressive and physical symptoms in depressed women.

AB - Objective: Hormone-based contraceptives affect mood in healthy women or in women with premenstrual dysphoric disorder (PMDD). No study has yet examined their association with mood in women with major depressive disorder (MDD). The purpose of this study was to determine whether estrogen-progestin combination or progestin-only contraceptives are associated with depression severity, function and quality of life, or general medical or psychiatric comorbidity in women with MDD. Methods: This analysis focused on a large population of female outpatients less than 40 years of age with non-psychotic MDD who were treated in 18 primary and 23 psychiatric care settings across the US, using data from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study. Baseline demographic and clinical information was gathered and compared between three groups based on hormonal use: combination (estrogen-progestin)(N=232), progestin-only (N=58), and no hormone treatment (N=948). Results: Caucasians were significantly more likely to use combined hormone contraception. Women on progestin-only had significantly more general medical comorbidities; greater hypersomnia, weight gain and gastrointestinal symptoms; and worse physical functioning than women in either of the other groups. Those on combined hormone contraception were significantly less depressed than those with no hormone treatment by the 16-item Quick Inventory of Depressive Symptomatology-Self-Rated. The combined hormone group also demonstrated better physical functioning and less obsessive-compulsive disorder (COCD) comorbidity than either of the other groups. Conclusions: Synthetic estrogen and progestins may influence depressive and physical symptoms in depressed women.

KW - Estradiol

KW - Major depression

KW - Mood symptoms

KW - Norplant

KW - Oral contraceptives

KW - Progesterone

UR - http://www.scopus.com/inward/record.url?scp=34547595690&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547595690&partnerID=8YFLogxK

U2 - 10.1016/j.psyneuen.2007.05.013

DO - 10.1016/j.psyneuen.2007.05.013

M3 - Article

C2 - 17629629

AN - SCOPUS:34547595690

VL - 32

SP - 843

EP - 853

JO - Psychoneuroendocrinology

JF - Psychoneuroendocrinology

SN - 0306-4530

IS - 7

ER -